RSS

intravenous

Biotechnology company, Phico Therapeutics, has been awarded significant funding from Innovate UK to support the manufacturing development of its intravenous antibiotic, SASPject PT3.8. more

News

A recent report from MarketIntelReports — ‘World Intravenous (IV) Ibuprofen Market — Opportunities and Forecast 2022’ — has estimated that the IV ibuprofen market will register a compound annual growth rate of 20% until 2022. more

News